z-logo
Premium
Elevated Serum Triglycerides with Clozapine Resolved with Risperidone in Four Patients
Author(s) -
Dufresne Robert L.,
Ghaeli Padideh
Publication year - 1999
Publication title -
pharmacotherapy: the journal of human pharmacology and drug therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.227
H-Index - 109
eISSN - 1875-9114
pISSN - 0277-0008
DOI - 10.1592/phco.19.13.1099.31586
Subject(s) - clozapine , risperidone , olanzapine , quetiapine , triglyceride , schizophrenia (object oriented programming) , medicine , atypical antipsychotic , hyperlipidemia , gastroenterology , endocrinology , pharmacology , antipsychotic , cholesterol , psychiatry , diabetes mellitus
Serum triglyceride levels of four patients with psychotic disorders were decreased after switching therapy from clozapine to risperidone. In two patients clozapine was reinstated after risperidone was discontinued; serum triglyceride levels increased. This increase when clozapine was switched to risperidone and vice versa is consistent with our previous report of elevated serum triglyceride levels in clozapine‐treated patients. Other reports show increases with the atypical antipsychotics, olanzapine and quetiapine. We believe serum triglyceride levels should be monitored in patients who have other cardiac risk factors and are receiving clozapine.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here